Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Heat treatment increases hair loss in certain mice.

Ginkgo biloba polysaccharides may reduce inflammation and promote hair growth in mice with hair loss.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

The immune system can cause permanent skin and hair whitening by attacking pigment cells.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Lupus hepatitis can affect male SLE patients and is treatable with specific medications.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Vitiligo is caused by the immune system attacking skin pigment cells.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Targeting specific T cells may help treat alopecia areata.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

Alopecia Areata patients have too many Firmicutes and too few Bacteroides in their gut.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Type I interferons play a key role in the development of various skin diseases.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Melatonin reduced oxidative stress and might improve hair growth in alopecia areata patients.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.